May 19, 2026
4-minute read

Scalable Synthesis of Cantharidin: a new TAPI R&D publication highlighting DoE-driven process and crystallization excellence 

At TAPI, scientific excellence is demonstrated through the way we design, optimize, and scale complex chemical processes. A newly published peer-reviewed paper from our R&D colleagues in Czechia, featured in Organic Process Research & Development (OPRD), highlights this approach through the development of a scalable synthetic route toward a key intermediate in Cantharidin.  The publication showcases TAPI’s capabilities in advanced chemistry, […]

Filter by:

Last Site Inspections

Feb 8, 2025

Teva API had a successful inspection in the Teva api Mexico site by Local MOH

Jan 15, 2025

Teva API had a successful inspection in the Teva api India, Gajraula site by Local MOH

Jan 4, 2025

Teva API had a successful inspection in the Teva api Croatia, Zagred site by Local MOH

Latest Catalog Updates

2026
Mavacamten
US DMF
2026
Zavegepant
US DMF
2026
Ixazomib Citrate
US DMF
2026
Voclosporin
EU DMF

Contact us

Step 1 of

    First name*
    Last name*
    Business email*
    Company*
    Job title*
    Country*
    I'm interested in*
    Segment of interest*
    Tell us more about your project
    Select product*
    Formulation
    Project type*
    Target market
    Quantity
    Comments
    Disclaimer: This material might be protected by exclusive rights such as patents and/or supplementary protection certificates or extensions in certain jurisdictions, and therefore might not be available for specific countries. TAPI will only be able to offer and supply this pharmaceutical ingredient in the countries and exclusively for uses that are exempt from infringement of such exclusive rights in accordance with applicable law. TAPI requires adequate confirmation of the exempt use upon ordering.
    By clicking submit, you are agreeing to our Privacy Policy